Crossref
BRAF/MEK Combination THERAPY for BRAF V600E Papillary and Anaplastic Thyroid Cancers: Additional Data from Real-World Use
Clinical Thyroidology® · 01.03.2026 · 38 (3) · 87-91
DOI: 10.1177/23299711261436475 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Thyroidology®, online erschienen am 22.04.2026. Verfasst von Sinthia Vidal Cañas und 1 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Cañas, S. V., & Chuki, E. (2026). BRAF/MEK Combination THERAPY for BRAF V600E Papillary and Anaplastic Thyroid Cancers: Additional Data from Real-World Use. Clinical Thyroidology®, 38(3), 87-91. https://doi.org/10.1177/23299711261436475
Vancouver
Cañas SV, Chuki E. BRAF/MEK Combination THERAPY for BRAF V600E Papillary and Anaplastic Thyroid Cancers: Additional Data from Real-World Use. Clinical Thyroidology®. 2026;38(3):87-91. doi:10.1177/23299711261436475
BibTeX
@article{Caas2026,
author = {Cañas, Sinthia Vidal and Chuki, Elias},
title = {BRAF/MEK Combination THERAPY for BRAF V600E Papillary and Anaplastic Thyroid Cancers: Additional Data from Real-World Use},
journal = {Clinical Thyroidology®},
year = {2026},
volume = {38},
number = {3},
pages = {87--91},
doi = {10.1177/23299711261436475}
}
EUVIMED